Literature DB >> 17989366

Influence of patient age and stenosis location on wingspan in-stent restenosis.

A S Turk1, E I Levy, F C Albuquerque, G L Pride, H Woo, B G Welch, D B Niemann, P D Purdy, B Aagaard-Kienitz, P A Rasmussen, L N Hopkins, T J Masaryk, C G McDougall, D Fiorella.   

Abstract

BACKGROUND AND
PURPOSE: Wingspan is a self-expanding, microcatheter-delivered microstent specifically designed for the treatment of symptomatic intracranial atherosclerotic disease. Our aim was to discuss the effect of patient age and lesion location on in-stent restenosis (ISR) rates after percutaneous transluminal angioplasty and stenting (PTAS) with the Wingspan system.
MATERIALS AND METHODS: Clinical and angiographic follow-up results were recorded for all patients from 5 participating institutions. ISR was defined as >50% stenosis within or immediately adjacent (within 5 mm) to the implanted stent and >20% absolute luminal loss. For the present analysis, patients were stratified into younger (</=55 years) and older (>55 years) age groups.
RESULTS: ISR occurred at a rate of 45.2% (14/31) in the younger group and 24.2% (15/62) in the older group (odds ratio, 2.6; 95% confidence interval, 1.03-6.5). In the younger group, ISR occurred after treatment of 13/26 (50%) anterior circulation lesions versus only 1/5 (20%) posterior circulation lesions. In the older group, ISR occurred in 9/29 (31.0%) anterior circulation lesions and 6/33 (18.2%) posterior circulation lesions. In young patients, internal carotid artery lesions (10/17 treated, 58.8%), especially those involving the supraclinoid segment (8/9, 88.9%), were very prone to ISR. When patients of all ages were considered, supraclinoid segment lesions had much higher rates of both ISR (66.6% versus 24.4%) and symptomatic ISR (40% versus 3.9%) in comparison with all other locations.
CONCLUSION: Post-Wingspan ISR is more common in younger patients. This increased risk can be accounted for by a high prevalence of anterior circulation lesions in this population, specifically those affecting the supraclinoid segment, which are much more prone to ISR and symptomatic ISR than all other lesions.

Entities:  

Mesh:

Year:  2007        PMID: 17989366      PMCID: PMC8119103          DOI: 10.3174/ajnr.A0869

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  10 in total

1.  Safety, feasibility, and short-term follow-up of drug-eluting stent placement in the intracranial and extracranial circulation.

Authors:  Rishi Gupta; Firas Al-Ali; Ajith J Thomas; Michael B Horowitz; Thomas Barrow; Nirav A Vora; Ken Uchino; Maxim D Hammer; Lawerence R Wechsler; Tudor G Jovin
Journal:  Stroke       Date:  2006-09-07       Impact factor: 7.914

2.  Wingspan in-stent restenosis and thrombosis: incidence, clinical presentation, and management.

Authors:  Elad I Levy; Aquilla S Turk; Felipe C Albuquerque; David B Niemann; Beverly Aagaard-Kienitz; Lee Pride; Phil Purdy; Babu Welch; Henry Woo; Peter A Rasmussen; L Nelson Hopkins; Thomas J Masaryk; Cameron G McDougall; David J Fiorella
Journal:  Neurosurgery       Date:  2007-09       Impact factor: 4.654

3.  Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials.

Authors:  Anthony A Bavry; Dharam J Kumbhani; Thomas J Helton; Przemyslaw P Borek; Girish R Mood; Deepak L Bhatt
Journal:  Am J Med       Date:  2006-12       Impact factor: 4.965

4.  Intracranial angioplasty without stenting for symptomatic atherosclerotic stenosis: long-term follow-up.

Authors:  Michael P Marks; Mary L Marcellus; Huy M Do; Pamela K Schraedley-Desmond; Gary K Steinberg; David C Tong; Gregory W Albers
Journal:  AJNR Am J Neuroradiol       Date:  2005-03       Impact factor: 3.825

5.  Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis.

Authors:  Marc I Chimowitz; Michael J Lynn; Harriet Howlett-Smith; Barney J Stern; Vicki S Hertzberg; Michael R Frankel; Steven R Levine; Seemant Chaturvedi; Scott E Kasner; Curtis G Benesch; Cathy A Sila; Tudor G Jovin; Jose G Romano
Journal:  N Engl J Med       Date:  2005-03-31       Impact factor: 91.245

6.  Intracranial angioplasty and stenting: long-term results from a single center.

Authors:  J C Wojak; D C Dunlap; K R Hargrave; L A DeAlvare; H S Culbertson; J J Connors
Journal:  AJNR Am J Neuroradiol       Date:  2006-10       Impact factor: 3.825

7.  US multicenter experience with the wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results.

Authors:  David Fiorella; Elad I Levy; Aquilla S Turk; Felipe C Albuquerque; David B Niemann; Beverly Aagaard-Kienitz; Ricardo A Hanel; Henry Woo; Peter A Rasmussen; L Nelson Hopkins; Thomas J Masaryk; Cameron G McDougall
Journal:  Stroke       Date:  2007-02-08       Impact factor: 7.914

8.  A 7-year experience with balloon-mounted coronary stents for the treatment of symptomatic vertebrobasilar intracranial atheromatous disease.

Authors:  David Fiorella; Michael M Chow; Michael Anderson; Henry Woo; Peter A Rasmussen; Thomas J Masaryk
Journal:  Neurosurgery       Date:  2007-08       Impact factor: 4.654

9.  Angioplasty for symptomatic intracranial stenosis: clinical outcome.

Authors:  Michael P Marks; Joan C Wojak; Firas Al-Ali; Mahesh Jayaraman; Mary L Marcellus; John J Connors; Huy M Do
Journal:  Stroke       Date:  2006-02-23       Impact factor: 7.914

10.  Midterm outcomes of paclitaxel-eluting stents for the treatment of intracranial posterior circulation stenoses.

Authors:  Brendan Steinfort; Perry P Ng; Kenneth Faulder; Timothy Harrington; Verity Grinnell; William Sorby; Michael K Morgan
Journal:  J Neurosurg       Date:  2007-02       Impact factor: 5.115

  10 in total
  49 in total

Review 1.  Symptomatic intracranial arterial disease: incidence, natural history, diagnosis, and management.

Authors:  Ananth K Vellimana; Andria L Ford; Jin-Moo Lee; Colin P Derdeyn; Gregory J Zipfel
Journal:  Neurosurg Focus       Date:  2011-06       Impact factor: 4.047

2.  Stent angioplasty of intracranial stenosis: single center experience of 54 cases.

Authors:  F Dorn; S Prothmann; S Wunderlich; T Liebig
Journal:  Clin Neuroradiol       Date:  2011-09-21       Impact factor: 3.649

3.  Angiographic CT after intravenous contrast agent application: A noninvasive follow-up tool after intracranial angioplasty and stenting.

Authors:  M-N Psychogios; P Schramm; J-H Buhk; A Xyda; K Gröschel; K Jung; M Knauth
Journal:  AJNR Am J Neuroradiol       Date:  2010-07-15       Impact factor: 3.825

4.  Clinical features and outcome in North American adults with idiopathic basal arterial occlusive disease without moyamoya collaterals.

Authors:  Manu S Goyal; Christopher L Hallemeier; Gregory J Zipfel; Keith M Rich; Robert L Grubb; Michael R Chicoine; Christopher J Moran; DeWitte T Cross; Ralph G Dacey; Colin P Derdeyn
Journal:  Neurosurgery       Date:  2010-08       Impact factor: 4.654

5.  Comment on: Mechanical thrombectomy with the Solitaire AB device in large artery occlusions of the anterior circulation: Castaño C, Dorado L, Guerrero C, et al. Stroke. 2010;41:1836-40.

Authors:  S Stampfl; S Rohde
Journal:  Clin Neuroradiol       Date:  2010-12-03       Impact factor: 3.649

6.  How do we spin wingspan?

Authors:  D F Kallmes; H J Cloft
Journal:  AJNR Am J Neuroradiol       Date:  2007-11-26       Impact factor: 3.825

7.  Intracranial stent restenosis diagnosed on routine duplex follow-up investigation.

Authors:  K Gröschel; S Schnaudigel; J H Buhk; M Knauth; A Kastrup
Journal:  AJNR Am J Neuroradiol       Date:  2008-07-18       Impact factor: 3.825

8.  Temporal correlation between wall shear stress and in-stent stenosis after Wingspan stent in swine model.

Authors:  M Fujimoto; H Takao; T Suzuki; Y Shobayashi; F Mayor; S Tateshima; M Yamamoto; Y Murayama; F Viñuela
Journal:  AJNR Am J Neuroradiol       Date:  2013-11-14       Impact factor: 3.825

9.  Incidence and Risk Factors of In-Stent Restenosis for Symptomatic Intracranial Atherosclerotic Stenosis: A Systematic Review and Meta-Analysis.

Authors:  G Peng; Y Zhang; Z Miao
Journal:  AJNR Am J Neuroradiol       Date:  2020-07-30       Impact factor: 3.825

Review 10.  Current strategies for the treatment of intracranial atherosclerotic internal carotid artery stenosis.

Authors:  Toral R Patel; Ketan R Bulsara
Journal:  Neurosurg Rev       Date:  2008-09-26       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.